- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03559959
A Field Experiment to Assess the Demand for HIV Self-Tests in Zimbabwe
February 27, 2019 updated by: Harsha Thirumurthy, University of Pennsylvania
This study is a field experiment in peri-urban and rural communities near Harare, Zimbabwe, that seeks to estimate the likelihood that individuals will purchase HIV self-tests under various pricing and distribution strategies.
About 4,000 adults will be randomly selected, administered a short questionnaire, and given vouchers that will offer them HIV self-tests at randomly allocated prices and distribution sites.
The study will also test whether the provision of HIV self-tests can be targeted more cost-effectively to reach high-risk persons and non- recent testers.
Last, the study will explore whether demand for repeated HIV self-testing is contingent on the price offered initially.
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
This study is a field experiment that seeks to obtain "revealed preference" estimates of the likelihood that individuals will purchase oral fluid-based HIV self-tests at alternative prices.
Such an approach is useful for estimating the price sensitivity (or elasticity) of demand for HIV self-tests.
The study will also estimate the extent to which demand for self-tests differs by certain distribution channels such as retail outlets, public sector health facilities, and other community-based venues.
Importantly, the experiment will also test whether the provision of HIV self-tests can be targeted more cost-effectively to reach high-risk persons and non-recent testers by examining the demand for self-tests in these populations in responses to various prices and distribution strategies.
The results of the study will provide vital information required by policy makers and implementers on the optical pricing and distribution strategies for introducing HIV self-tests and scaling up HIVST in resource-limited settings.
In a subsequent study with additional funding, the study will also seek to determine the long-term implications of offering self-tests at very low prices initially; specifically, it will assess whether free distribution initially suppresses individuals' willingness to pay for self-tests in the future.
Roughly 12 months after the initial voucher offer, participants who provided a mobile phone number they can access within their household will be contacted via phone-based text messages and offered the same HIV self-tests again at one common non-zero price.
The purchases at 12 months will once again be monitored and linked to participants via a unique identifier that is included in the text messages.
Study Type
Interventional
Enrollment (Actual)
4000
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Harare, Zimbabwe
- Zimbabwe and the Centre for Sexual Health and HIV/AIDS Research (CeSHHAR) Zimbabwe
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
16 years and older (Child, Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Age 16 years or older
- Willing and able to provide written informed consent for participation
- Intends to stay in the study area for at least 12 months
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Screening
- Allocation: Randomized
- Interventional Model: Factorial Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: $0 price
Vouchers for HIV self-testing kits: Individuals will receive a voucher that can be used to redeem an HIV self-testing kit free of charge.
|
Participants will be given one referral voucher that offers a self-test kit at a randomly selected price point and distribution site.
The vouchers will be valid for one month after the enrollment date.
The other household members above 16 years of age will also be offered one voucher per person.
Vouchers for the same household will have the same price, distributor, and promotion messages.
|
|
Experimental: $0.5 price
Vouchers for HIV self-testing kits: Individuals will receive a voucher that can be used to purchase an HIV self-testing kit at the price of $0.5.
|
Participants will be given one referral voucher that offers a self-test kit at a randomly selected price point and distribution site.
The vouchers will be valid for one month after the enrollment date.
The other household members above 16 years of age will also be offered one voucher per person.
Vouchers for the same household will have the same price, distributor, and promotion messages.
|
|
Experimental: $1 price
Vouchers for HIV self-testing kits: Individuals will receive a voucher that can be used to purchase an HIV self-testing kit at the price of $1.
|
Participants will be given one referral voucher that offers a self-test kit at a randomly selected price point and distribution site.
The vouchers will be valid for one month after the enrollment date.
The other household members above 16 years of age will also be offered one voucher per person.
Vouchers for the same household will have the same price, distributor, and promotion messages.
|
|
Experimental: $2 price
Vouchers for HIV self-testing kits: Individuals will receive a voucher that can be used to purchase an HIV self-testing kit at the price of $2.
|
Participants will be given one referral voucher that offers a self-test kit at a randomly selected price point and distribution site.
The vouchers will be valid for one month after the enrollment date.
The other household members above 16 years of age will also be offered one voucher per person.
Vouchers for the same household will have the same price, distributor, and promotion messages.
|
|
Experimental: $3 price
Vouchers for HIV self-testing kits: Individuals will receive a voucher that can be used to purchase an HIV self-testing kit at the price of $3.
|
Participants will be given one referral voucher that offers a self-test kit at a randomly selected price point and distribution site.
The vouchers will be valid for one month after the enrollment date.
The other household members above 16 years of age will also be offered one voucher per person.
Vouchers for the same household will have the same price, distributor, and promotion messages.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Voucher redemption
Time Frame: One month after enrollment
|
Proportion of individuals that obtained or purchased an HIV self-test
|
One month after enrollment
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Voucher redemption in key populations
Time Frame: One month
|
Proportion of individuals that obtained or purchased an HIV self-test in key segments of the populations, including individuals who have never tested for HIV in the past or not tested recently, individuals with high risk of HIV infection based on self-reported sexual behavior, and individuals with low and high income.
|
One month
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 15, 2018
Primary Completion (Actual)
May 25, 2018
Study Completion (Actual)
May 25, 2018
Study Registration Dates
First Submitted
June 5, 2018
First Submitted That Met QC Criteria
June 5, 2018
First Posted (Actual)
June 18, 2018
Study Record Updates
Last Update Posted (Actual)
February 28, 2019
Last Update Submitted That Met QC Criteria
February 27, 2019
Last Verified
February 1, 2019
More Information
Terms related to this study
Additional Relevant MeSH Terms
- RNA Virus Infections
- Virus Diseases
- Infections
- Blood-Borne Infections
- Communicable Diseases
- Sexually Transmitted Diseases, Viral
- Sexually Transmitted Diseases
- Lentivirus Infections
- Retroviridae Infections
- Immunologic Deficiency Syndromes
- Immune System Diseases
- Slow Virus Diseases
- HIV Infections
- Acquired Immunodeficiency Syndrome
Other Study ID Numbers
- MRCZ/A/2199
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
No
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV/AIDS
-
University of MinnesotaWithdrawnHIV Infections | HIV/AIDS | Hiv | AIDS | Aids/Hiv Problem | AIDS and InfectionsUnited States
-
University of California, San DiegoNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of Massachusetts, BostonCompleted
-
Stanford UniversityJanssen Services, LLCCompleted
-
ViiV HealthcareJohns Hopkins University; Pfizer; Vanderbilt University; University of North Carolina...Completed
-
Medical College of WisconsinCompleted
-
Emory UniversityCompleted
-
Rhode Island HospitalUnknown
-
Tibotec Pharmaceuticals, IrelandCompleted
-
Lampiris, Harry W., M.D.AbbottUnknown
Clinical Trials on Vouchers for HIV self-testing kits
-
University of WashingtonCompleted
-
Chinese University of Hong KongCompleted
-
HIV Prevention Trials NetworkNational Institute of Allergy and Infectious Diseases (NIAID)Completed
-
University of MichiganNational Institute of Mental Health (NIMH)Enrolling by invitationHIV Prevention | Pre-Exposure Prophylaxis (PrEP)United States
-
University of California, Los AngelesEmory University; BroadReach Healthcare; USAID, South Africa; South African Department...CompletedHIV Infections | HIV Seropositivity | ARTSouth Africa
-
Chinese University of Hong KongCompletedSTI | Mycoplasma Genitalium InfectionHong Kong
-
Harvard School of Public Health (HSPH)University of Heidelberg Medical Center; University of Witwatersrand, South...UnknownHIV Infections | Knowledge, Attitudes, PracticeSouth Africa
-
London School of Hygiene and Tropical MedicineWorld Health Organization; UNITAID; Liverpool School of Tropical MedicineUnknownHIV Infections | HIV/AIDSMalawi
-
London School of Hygiene and Tropical MedicineUniversity College, London; World Health Organization; UNITAID; Liverpool School... and other collaboratorsCompleted
-
Boston UniversityNational Institute of Dental and Craniofacial Research (NIDCR)Not yet recruiting